Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Furong Paotengshuan (also known as Fufang Furong Effervescent Suppository) is a traditional Chinese medicine (TCM) vaginal effervescent suppository developed and manufactured by Shaanxi Momentum Qixuehe Pharmaceutical. It is formulated from six herbal ingredients: Sophorae Flavescentis Radix (Kushen), Cnidii Fructus (Shechuangzi), Phellodendri Chinensis Cortex (Huangbai), Hibisci Mutabilis Folium (Mufurongye), Artemisiae Argyi Folium (Aiye), and Alumen (Baifan). The formulation is approved in China for the treatment of damp-heat pruritus vulvae, trichomonas vaginitis, mycotic vaginitis, and bacterial vaginosis. It has also been evaluated in clinical trials for the treatment of aerobic vaginitis and mixed vaginitis, demonstrating efficacy in restoring vaginal microecological balance and promoting Lactobacillus recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fufang Furong Paotengshuan.